CKD: LAI Recommendations

A combination of statins/statin plus ezetimibe is recommended

in all adults over the age of 40 years with chronic

kidney disease (CKD) stage 3 or higher.

In adults between the ages of 18 and 39 with CKD should

be treated with statins if they have one of the following:

Known coronary artery disease (CAD), stroke or

peripheral vascular disease

Diabetes mellitus

Life-time risk of atherosclerotic cardiovascular disease (ASCVD) >30%.

Patients who are already receiving lipid-lowering therapy at the time of starting

dialysis should continue to receive these agents.